Sandra K. Althouse
- Hepatology top 5%
- Oncology top 5%
- Cancer Immunotherapy and Biomarkers 17
-
- Lung Cancer Treatments and Mutations 19
- Sarcoma Diagnosis and Treatment 17
- Lung Cancer Diagnosis and Treatment 7
- Cancer Research top 10%
- Cancer Genomics and Diagnostics 6
- Reproductive Medicine top 5%
-
- Testicular diseases and treatments 30
-
- Neuroblastoma Research and Treatments 15
-
- Childhood Cancer Survivors' Quality of Life 6
- Co-authors
- Nasser H. HannaLawrence H. EinhornNabil AdraSusan M. PerkinsCostantine AlbanyHiginia R. CárdenesEdward M. ManninaMary A. Maluccio
- Partner nations
- United StatesCanadaUnited Kingdom
In The Last Decade
Sandra K. Althouse
95 papers receiving 1.5k citations
Peers
Comparison fields: 5 of 104
- Hepatology 208
- Oncology 472
- Pulmonary and Respiratory Medicine 500
- Cancer Research 212
- Reproductive Medicine 117
Countries citing papers authored by Sandra K. Althouse
This map shows the geographic impact of Sandra K. Althouse's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sandra K. Althouse with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sandra K. Althouse more than expected).
Fields of papers citing papers by Sandra K. Althouse
This network shows the impact of papers produced by Sandra K. Althouse. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sandra K. Althouse. The network helps show where Sandra K. Althouse may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Sandra K. Althouse, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 1 | |
| 2 | 2024 | 1 | |
| 3 | 2024 | 2 | |
| 4 | 2024 | 4 | |
| 5 | 2023 | 4 | |
| 6 | 2023 | 9 | |
| 7 | 2023 | 4 | |
| 8 | 2023 | 5 | |
| 9 | 2023 | 1 | |
| 10 | 2022 | 19 | |
| 11 | 2022 | 1 | |
| 12 | 2022 | 21 | |
| 13 | 2022 | 1 | |
| 14 | 2022 | 0 | |
| 15 | 2021 | 6 | |
| 16 | 2020 | 116 | |
| 17 | 2020 | 3 | |
| 18 | Multi-Institutional Assessment of Adverse Health Outcomes Among North American Testicular Cancer Survivors After Modern Cisplatin-Based Chemotherapy | 2017 | 1 |
| 19 | 2017 | 4 | |
| 20 | 2014 | 36 |
About Sandra K. Althouse
Sandra K. Althouse is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Neurology, having authored 105 papers that have together received 1.5k indexed citations. Recurring topics across this work include Testicular diseases and treatments (30 papers), Lung Cancer Treatments and Mutations (19 papers), Cancer Immunotherapy and Biomarkers (17 papers), Sarcoma Diagnosis and Treatment (17 papers), Neuroblastoma Research and Treatments (15 papers), Lung Cancer Diagnosis and Treatment (7 papers), Cancer Genomics and Diagnostics (6 papers) and Childhood Cancer Survivors' Quality of Life (6 papers). The work is most often cited by research in Hepatology (208 citations), Oncology (472 citations) and Pulmonary and Respiratory Medicine (500 citations). Sandra K. Althouse has collaborated with scholars based in United States, Canada and United Kingdom. Frequent co-authors include Nasser H. Hanna, Lawrence H. Einhorn, Nabil Adra, Susan M. Perkins, Costantine Albany, Higinia R. Cárdenes, Edward M. Mannina, Mary A. Maluccio, David J. Vaughn and Rafat Abonour. Their work appears in journals such as Journal of Clinical Oncology, Clinical Lung Cancer, Cancer, Clinical Genitourinary Cancer and Journal of Adolescent and Young Adult Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.